Dean C. Pavlick

4.4k total citations
92 papers, 1.4k citations indexed

About

Dean C. Pavlick is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dean C. Pavlick has authored 92 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 40 papers in Cancer Research and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dean C. Pavlick's work include Cancer Genomics and Diagnostics (37 papers), Lung Cancer Treatments and Mutations (18 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers). Dean C. Pavlick is often cited by papers focused on Cancer Genomics and Diagnostics (37 papers), Lung Cancer Treatments and Mutations (18 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers). Dean C. Pavlick collaborates with scholars based in United States, Italy and Japan. Dean C. Pavlick's co-authors include Jeffrey S. Ross, Siraj M. Ali, Vincent A. Miller, Garrett M. Frampton, Shridar Ganesan, Alexa B. Schrock, Jon Chung, Janice M. Mehnert, Anshuman Panda and Gyan Bhanot and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Dean C. Pavlick

87 papers receiving 1.3k citations

Peers

Countries citing papers authored by Dean C. Pavlick

Since Specialization

Citations

This map shows the geographic impact of Dean C. Pavlick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean C. Pavlick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean C. Pavlick more than expected).

Fields of papers citing papers by Dean C. Pavlick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean C. Pavlick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean C. Pavlick. The network helps show where Dean C. Pavlick may publish in the future.

Co-authorship network of co-authors of Dean C. Pavlick

This figure shows the co-authorship network connecting the top 25 collaborators of Dean C. Pavlick. A scholar is included among the top collaborators of Dean C. Pavlick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dean C. Pavlick. Dean C. Pavlick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Squamous cell carcinoma of unknown primary (SCCUP): a genomic landscape study 2025 ·ESMO Open ·(unknown), (unknown), Dean C. Pavlick, S. Lindsey Davis, Christopher H. Lieu, (unknown), Laura Graham, Philippe E. Spiess, Ruichao Li, Ashish M. Kamat, Petros Grivas, (unknown), Gennady Bratslavsky, (unknown), Kum Thong Wong, Douglas I. Lin, Andrea Necchi, Jeffrey S. Ross, Elaine T. Lam	0
2	Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2 2024 ·Modern Pathology ·Jessica M. Posada, Evgeny Yakirevich, Ashish M. Kamat, Anil K. Sood, Joseph M Jacob, Gennady Bratslavsky, Petros Grivas, Philippe E. Spiess, Roger Li, Andrea Necchi, Anthony Mega, (unknown), Dean C. Pavlick, Richard S.P. Huang, D. N. C. Lin, Natalie Danziger, Ethan S. Sokol, Smruthy Sivakumar, Jeffrey S. Ross, Liang Cheng	8
3	Age and Sex Affects the Frequency and Mutation Type of FGFR2 Alterations in Cholangiocarcinoma 2024 ·Zilun Hu, Jeffrey S. Ross, Dean C. Pavlick, David Hsiehchen	0
4	Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma 2024 ·Journal of Translational Medicine ·Michael J. Dennis, Dean C. Pavlick, Alec Kacew, Michael Wotman, Laura E. MacConaill, Stephanie M. Jones, Kathleen L. Pfaff, Scott J. Rodig, Stephen Eacker, Maika Malig, (unknown), David Piccioni, Santosh Kesari, Kartik Sehgal, Robert I. Haddad, Ezra E.W. Cohen, Marshall R. Posner, Ida Deichaite, Glenn J. Hanna	2
5	Evaluation of tissue- and plasma-derived tumor mutational burden (TMB) and genomic alterations of interest in CheckMate 848, a study of nivolumab combined with ipilimumab and nivolumab alone in patients with advanced or metastatic solid tumors with high TMB 2023 ·Journal for ImmunoTherapy of Cancer ·Jie He, Natallia Kalinava, Parul Doshi, Dean C. Pavlick, Lee A. Albacker, Ericka M. Ebot, (unknown), James Pratt, Gina Fusaro, Geoffrey R. Oxnard, George Green, (unknown), Jonathan Baden	14
6	Comparative Genomic Analysis and Clinical Outcomes of BRAF -mutated Advanced Biliary Tract Cancers 2023 ·Clinical Cancer Research ·(unknown), Federico Nichetti, (unknown), Sara Lonardi, Filippo Pietrantonio, Lisa Salvatore, Caterina Vivaldi, Lorenza Rimassa, Filippo de Braud, Mario Domenico Rizzato, Dean C. Pavlick, (unknown), (unknown), Radwa Sharaf, Ethan Sokol, Jordi Rodón, Jeffrey S. Ross, Milind Javle, Monica Niger	8
7	Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1/2, Germline PALB2, or Homologous Recombination Deficiency Signature 2023 ·JCO Precision Oncology ·Felipe Batalini, Russell W. Madison, Ethan S. Sokol, Dexter X. Jin, (unknown), Brennan Decker, Dean C. Pavlick, Garrett M. Frampton, Gerburg M. Wulf, Judy E. Garber, Geoffrey R. Oxnard, Alexa B. Schrock, Nadine Tung	8
8	Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry 2023 ·The Oncologist ·Taylor Peak, Philippe E. Spiess, Roger Li, Petros Grivas, Andrea Necchi, Dean C. Pavlick, Richard S.P. Huang, Douglas I. Lin, Natalie Danziger, Joseph M Jacob, Gennady Bratslavsky, Jeffrey S. Ross	1
9	Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy 2023 ·The Oncologist ·(unknown), Dean C. Pavlick, Yihong Wang, Benedito A. Carneiro, (unknown), Shaolei Lu, (unknown), Gennady Bratslavsky, Joseph M Jacob, Andrea Necchi, Philippe E. Spiess, Li Wang, Evgeny Yakirevich, Jeffrey S. Ross	9
10	Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA Samples 2022 ·JCO Precision Oncology ·Hatim Husain, Dean C. Pavlick, Bernard J. Fendler, Russell W. Madison, Brennan Decker, Ole Gjoerup, Christine A. Parachoniak, (unknown), Rachel Erlich, Alexa B. Schrock, Garrett M. Frampton, Meghna Das Thakur, Geoffrey R. Oxnard, Hanna Tukachinsky	58
11	FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas 2021 ·Neuro-Oncology Advances ·Radwa Sharaf, Dean C. Pavlick, Garrett M. Frampton, Maureen Cooper, (unknown), Natalie Danziger, James Haberberger, Brian M. Alexander, Timothy F. Cloughesy, William H. Yong, Linda M. Liau, Phioanh L. Nghiemphu, (unknown), Albert Lai, Shakti Ramkissoon, Lee A. Albacker	4
12	Pan-cancer landscape of CD274 (PD-L1) copy number changes in 244 584 patient samples and the correlation with PD-L1 protein expression 2021 ·Journal for ImmunoTherapy of Cancer ·Richard S.P. Huang, Karthikeyan Murugesan, Meagan Montesion, Dean C. Pavlick, Douglas A. Mata, Matthew Hiemenz, Brennan Decker, Garrett M. Frampton, Lee A. Albacker, Jeffrey S. Ross	16
13	Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma 2021 ·JCO Precision Oncology ·Karthikeyan Murugesan, Radwa Sharaf, Meagan Montesion, Jay A. Moore, (unknown), Dean C. Pavlick, Garrett M. Frampton, Vivek Upadhyay, Brian M. Alexander, Vincent A. Miller, Milind Javle, Tanios Bekaii‐Saab, Lee A. Albacker, Jeffrey S. Ross, Siraj M. Ali	12
14	CDKN2C -Null Leiomyosarcoma: A Novel, Genomically Distinct Class of TP53 / RB1 –Wild-Type Tumor With Frequent CIC Genomic Alterations and 1p/19q-Codeletion 2020 ·JCO Precision Oncology ·Erik A. Williams, Radwa Sharaf, Brennan Decker, (unknown), (unknown), Meagan Montesion, Ethan S. Sokol, Dean C. Pavlick, (unknown), Kevin Jon Williams, Jeffrey M. Venstrom, Brian M. Alexander, Jeffrey S. Ross, Lee A. Albacker, Douglas I. Lin, Shakti Ramkissoon, Julia A. Elvin	10
15	Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations 2020 ·Modern Pathology ·Erik A. Williams, Meagan Montesion, (unknown), Radwa Sharaf, Dean C. Pavlick, Ethan Sokol, Brian M. Alexander, (unknown), Julia A. Elvin, Jeffrey S. Ross, Kevin Jon Williams, Julie Y. Tse, Mark C. Mochel	20
16	Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles 2020 ·Modern Pathology ·Erik A. Williams, (unknown), Meagan Montesion, Radwa Sharaf, Dean C. Pavlick, Ethan Sokol, Brian M. Alexander, (unknown), Julia A. Elvin, Jeffrey S. Ross, Julie Y. Tse, Mark C. Mochel	32
17	CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinoma 2020 ·Modern Pathology ·Erik A. Williams, Meagan Montesion, Radwa Sharaf, (unknown), (unknown), (unknown), Dean C. Pavlick, Ethan S. Sokol, Brian M. Alexander, Kevin Jon Williams, Julia A. Elvin, Jeffrey S. Ross, Shakti Ramkissoon, Amanda Hemmerich, Julie Y. Tse, Mark C. Mochel	9
18	Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus 2018 ·Clinical Cancer Research ·Alexa B. Schrock, Dean C. Pavlick, Samuel J. Klempner, Jon Chung, (unknown), Allison W. Welsh, Lauren Young, B Leyland-Jones, Rodolfo Bordoni, Richard D. Carvajal, Joseph Chao, Razelle Kurzrock, Jason K. Sicklick, Jeffrey S. Ross, Philip J. Stephens, Craig Devoe, Fadi Braiteh, Siraj M. Ali, Vincent A. Miller	54
19	Genomic profiling of 114,200 advanced cancers identifies recurrent kinase domain duplications (KDD) and oncogenic rearrangements (RE) across diverse tumor types 2017 ·Annals of Oncology ·(unknown), Dean C. Pavlick, Jon Chung, (unknown), (unknown), Julia A. Elvin, Eric A. Severson, Trever G. Bivona, Karen L. Reckamp, Samuel J. Klempner, S.-H.I. Ou, Alexa B. Schrock, V.A. Miller, (unknown), Jeffrey S. Ross, Shridar Ganesan, Christine M. Lovly, Aaron S. Mansfield, Siraj M. Ali	4
20	Comprehensive Genomic Profiling (CGP) of 114,200 advanced cancers identifies recurrent Kinase Domain Duplications (KDD) and novel oncogenic fusions in diverse tumor types 2017 ·Annals of Oncology ·Sadakatsu Ikeda, Laurie M. Gay, Dean C. Pavlick, Jon Chung, (unknown), (unknown), Julia A. Elvin, Eric A. Severson, Trever G. Bivona, Karen L. Reckamp, Samuel J. Klempner, S.-H.I. Ou, Alexa B. Schrock, V.A. Miller, Peter Stephens, Jeffrey A. Ross, Shridar Ganesan, Christine M. Lovly, Aaron S. Mansfield, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact